Acute myeloid leukemia (AML) is a rapidly progressing blood cancer that originates in the bone marrow and affects white blood cells. Rising prevalence of leukemia, growing awareness regarding early diagnosis, and increasing investments in oncology research are significantly contributing to market expansion. According to The Insight Partners, the market is projected to witness substantial growth...